• Zedstrian@lemmy.dbzer0.com
      link
      fedilink
      English
      arrow-up
      18
      arrow-down
      4
      ·
      edit-2
      1 year ago

      A success does not include leaving a victim of failed experimental medicine with a non-functional implant. In contrast to how animal subjects are used as test subjects (often conducted with less oversight than there should be), using experimental medicine on volunteering patients should be done not just to collect better data than the chimps before them supplied, but with the genuine expectation that the product in question will benefit the patient beyond their usefulness as a test subject for continued product development.

      • Grimy@lemmy.world
        link
        fedilink
        English
        arrow-up
        11
        arrow-down
        2
        ·
        edit-2
        1 year ago

        Through software updates, they were able to alleviate the problem. They are a bit vague in the article but it’s not a total loss and more than he had before the operation.

        Tbh though, the real test is how his brain accommodates it over the years and if it starts getting complicated later.

        • FaceDeer@fedia.io
          link
          fedilink
          arrow-up
          8
          arrow-down
          2
          ·
          1 year ago

          Also, this was the very first test implant into a human. At this point in testing “doesn’t harm the patient” is a perfectly good result to call a success.

          Honestly, people calling Neuralink a failure because the first patient didn’t get up and start dancing are just showing themselves to be either ignorant of the process or ridiculously biased.

      • FaceDeer@fedia.io
        link
        fedilink
        arrow-up
        7
        arrow-down
        5
        ·
        1 year ago

        SpaceX has a 64% market share in the global commercial rocket launch market for sending satellites, scientific instruments, and other payloads into orbit. In the first six months of 2023, SpaceX handled 21 flights for outside customers, or 64% of the worldwide total. In the first half of 2023, SpaceX handled 88 percent of customer flights from U.S. launch sites.[1]

        If success isn’t their goal I’d be amazed at what they accomplished if the decided to try for it someday.

        • FiniteBanjo@lemmy.today
          link
          fedilink
          English
          arrow-up
          1
          arrow-down
          4
          ·
          1 year ago

          That’s not analogous to the situation with the brain chips. We’re in the testing phases, and the testing phases for SpaceX rockets involves so many unplanned explosions that they’ve been in multiple investigations.

            • FiniteBanjo@lemmy.today
              link
              fedilink
              English
              arrow-up
              2
              arrow-down
              1
              ·
              1 year ago

              Yes and it stands. I’m still comparing SpaceX to Neuralink in terms of unethical rushed testing and development, and it still stands. What I’m not referring to is the products that SpaceX ships, YOU were the one who brought that up.